Enhancing Breast Cancer Management through PET Scans and Targeted Therapies

Please be informed that participation in the post-test assessment is mandatory for the issuance of certificates and the allocation of associated CPD points when finalized. Completion and passing of the post-test are required to validate your attendance and ensure compliance with CPD accreditation requirements for this session. Thank you for your cooperation and commitment to professional development.

PET Imaging & Targeted Therapies in Cancer: A Masterclass Series

SESSION ONE: The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care

The “PET Imaging & Targeted Therapies in Cancer” Masterclass Series is a unique and comprehensive educational series organized by the Sweden Ghana Medical Centre (SGMC) in partnership with Continuous Education Services (CES). This training program is designed to enhance healthcare professionals’ expertise in the use of PET (Positron Emission Tomography) imaging and advanced targeted therapies across various types of cancer. Participants will gain a deeper understanding of PET imaging’s critical role in cancer diagnosis, treatment planning, and patient monitoring, as well as the latest advancements in targeted therapies.

The series consists of five specialized sessions, each focusing on a specific cancer type and addressing its unique challenges and innovations in care. Each session will be led by highly qualified and experienced facilitators in oncology and medical imaging, bringing together theoretical insights and practical applications in an interactive format. The series will incorporate Q&A sessions to encourage in-depth discussions and ensure that participants gain actionable knowledge to apply in clinical practice.

SESSION BREAKDOWN

Each individual topic in the series has been carefully crafted to build on the knowledge acquired in previous sessions while allowing participants to engage deeply with each aspect of PET imaging and targeted therapies in cancer. The topics include:

Session 1: The Significance of PET Scans in Oncology: A Cornerstone of Modern Cancer Care

Session 2: Enhancing Breast Cancer Management through PET Scans and Targeted Therapies

Session 3: PET Imaging and Targeted Therapies in Hematological Malignancies

Session 4: Lung Cancer Diagnosis and Treatment: The Impact of PET Imaging and Targeted Therapies

Session 5: Prostate Cancer Management: The Role of PET Imaging and Advanced Therapies

EARN CPD POINTS

Participants will earn valuable CPD points upon successful completion of each session, supporting their continuous professional development and helping them stay at the forefront of advancements in cancer care. This credentialing underscores the commitment of SGMC to foster professional growth and knowledge enhancement in the medical community, ensuring that participants are recognized for their dedication to advancing patient outcomes.

WHY REGISTER AND ATTEND THIS TRAINING SERIES?

This masterclass series offers a unique opportunity to learn from renowned experts and gain cutting-edge knowledge in the rapidly evolving field of cancer diagnostics and treatment. Whether you're an oncologist, radiologist, or healthcare professional interested in oncology, attending these sessions will provide you with practical insights and the latest research to elevate patient care. Participants will also benefit from an interactive format, engaging directly with facilitators and peers through thought-provoking discussions and Q&A sessions.

SESSION 2: Enhancing Breast Cancer Management through PET Scans and Targeted Therapies

This session delves into the transformative impact of PET imaging and targeted therapies in breast cancer management. Participants will explore how PET imaging enhances the accuracy of staging, monitors therapeutic responses, and guides clinical decision-making. The session also highlights the critical role of targeted therapies in personalizing breast cancer treatment, emphasizing how PET scans can support the selection and optimization of these treatments. Facilitated by experts, this interactive session will equip participants with the knowledge to integrate advanced imaging and therapeutic strategies for improved patient outcomes.

ORGANIZED BY

PROUDLY SPONSORED BY

This virtual training will premier on Thursday the 21st of November 2024 at 4:00 PM.

Target Audience: Medical Doctors, Pharmacists, Nurses and Radiotherapists

Moderator: Dr. Amankwaa Frempong

Date: Thursday 21st November 2024

Time: 16:00 GMT (4:00 pm local time)

AGENDA

Thursday 21st November 2024 (VIRTUAL EVENT)

Overview

Course Description

The MASTERCLASS IN PET IMAGING & TARGETED THERAPIES FOR CANCER CARE begins with a foundational session, THE SIGNIFICANCE OF PET SCANS IN ONCOLOGY – A CORNERSTONE OF MODERN CANCER CARE. This session provides an in-depth exploration of how PET imaging has transformed oncology by enhancing the precision of cancer diagnosis, staging, treatment planning, and monitoring. Participants will gain a thorough understanding of the mechanisms behind PET technology and its unique ability to visualize metabolic activity in cancerous cells. Led by top experts in the field, this session also addresses the advantages and limitations of PET imaging, equipping attendees with practical insights to integrate PET into multidisciplinary cancer care for improved patient outcomes.

What you will learn

By the end of this session, participants will be able to:

1. Analyze the contribution of PET imaging to the staging and monitoring of breast cancer.

2. Evaluate the role of PET imaging in assessing treatment response and recurrence.

3. Understand the principles of targeted therapies in breast cancer management.

4. Integrate PET scan data into therapeutic decision-making processes.

5. Identify opportunities to personalize breast cancer care using PET-guided approaches.